Company Overview and News

5
Scoping Study Delivers Outstanding Results

2018-07-19 globenewswire
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Piedmont Lithium Limited (“Piedmont” or “Company”) (ASX:PLL) (NASDAQ:PLLL) is pleased to report the results of the Company’s Scoping Study for its vertically-integrated Piedmont Lithium Project (“Project”) located within the Carolina Tin-Spodumene Belt in North Carolina, USA (“TSB”). The Project includes a lithium hydroxide chemical plant (“Chemical Plant”) supplied with spodumene concentrate from an open pit mine and concentrator (“Mine/Concentrator”).
PDDTF PLLL LTUM ALB FTI.WI FMC

5
Piedmont Completes Bench-Scale Testwork Program To Produce Spodumene Concentrate

2018-07-17 globenewswire
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Piedmont Lithium Limited (“Piedmont” or “Company”) (ASX:PLL) (NASDAQ:PLLL) is pleased to report that the Company has completed a bench-scale metallurgical testwork program to produce spodumene concentrate from ore samples from the Company’s proposed vertically-integrated Piedmont Lithium Project located in North Carolina, USA. Piedmont has partnered with North Carolina State University’s Minerals Research Laboratory (MRL) to complete bench-scale testwork including spodumene flotation optimization, magnetic separation to remove iron from spodumene concentrate and Heavy Liquid Separation (HLS) to evaluate the potential for a Dense Medium Separation (DMS) circuit.
PDDTF PLLL LTUM ALB FTI.WI FMC

3
Domtar (UFS) Invests in Prisma to Boost Lignin Applications

2018-07-11 zacks
Domtar Corporation (UFS - Free Report) recently acquired a majority interest in Prisma Renewable Composites, LLC. This investment will help boost the process of commercializing Domtar’s lignin-based applications. Prisma Renewable Composites is a Knoxville-based spin-off of TennEra, LLC, which is primarily involved in the development of advanced materials from lignin and other natural resources. Per the investment, Domtar will employ Prisma's scientific research capabilities and unique product development strategy, alongwith its commercialization and lignin production expertise.
UPMKY KMG FTI.WI UFS FMC CE

1
Vale Rides on Stellar Steel Production Amid Inflating Costs

2018-07-11 zacks
On Jul 10, we issued an updated research report on Vale S.A. (VALE - Free Report) . The company’s performance will be backed by rise in global steel production and strong cash generation. However, its results might be marred by rising cost of sales and unfavorable exchange rates. Let’s illustrate these factors in detail. Rise in Steel Production to Boost Top Line Vale's net operating revenues in first-quarter 2018 benefited from elevated sales prices of the Base Metals segment and sturdier sales volumes of the Ferrous Minerals segment.
UPMKY KMG FTI.WI FMC CE

1
CE or PPG: Which Chemical Stock is Better Pre Q2 Earnings?

2018-07-11 zacks
The chemical industry is riding an upturn in the global economy and strength across major end-use markets such as construction and automotive. Improving fundamentals in the energy space driven by an upswing in crude oil prices also augur well for the industry. Notwithstanding a few headwinds, including a spike in raw materials costs and softness in agricultural commodity prices, chemical companies are expected to continue the earnings momentum witnessed in Q1 into Q2 as the fundamental driving factors remain in place.
PPG LYB FTI.WI FMC CE

3
Ingevity (NGVT) Stock Up 43% in a Year: What's Driving it?

2018-07-03 zacks
Shares of Ingevity Corporation (NGVT - Free Report) have rallied 43.3% in the past year against the industry’s decline of roughly 1.2%.
ABX WLK FTI.WI FMC NGVT CC NGVT.WI ABX

3
Here's Why You Should Add U.S. Steel (X) to Your Portfolio

2018-07-03 zacks
United States Steel Corporation’s (X - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it is poised to carry the momentum ahead. Let’s take a look into the factors that make this steel giant a compelling choice for investors right now. What’s Working in Favor of X? Solid Rank & VGM Score: U.
X ABX WLK FTI.WI FMC CC ABX

31
Here's Why You Should Add FMC Corp (FMC) to Your Portfolio

2018-07-02 zacks
FMC Corporation (FMC - Free Report) has been performing well of late. The chemical company has seen its shares pop around 17% over the past three months, outperforming the industry’s 3.6% rise. The price performance has been backed by strong first-quarter results and the company’s upward guidance revision for the full year. With strong fundamentals and solid long-term growth prospects, this stock can be considered a solid bet now.
VSM.WI WLK FTI.WI FMC VSM CC

26
Steel Dynamics (STLD) Wraps Up Heartland Buyout for $400M

2018-07-02 zacks
Steel Dynamics, Inc. (STLD - Free Report) has completed the previously announced acquisition of Heartland Steel Processing, LLC, formerly known as Companhia Siderurgica Nacional, LLC (Heartland), from CSN Steel, S.L.U., for $400 million in cash (including $60 million of normalized working capital), subject to customary transaction purchase price adjustments. The deal was funded with available cash with an expectation of near-term cash flow and earnings per share accretion.
STLD WLK FTI.WI FMC CC

26
5 Reasons to Add LyondellBasell (LYB) to Your Portfolio Now

2018-07-02 zacks
LyondellBasell Industries N.V.'s (LYB - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s delve deeper into the factors that make this chemical giant an intriguing choice for investors right now. What Makes LYB an Attractive Pick? Solid Rank & VGM Score: LyondellBasell currently has a Zacks Rank #2 (Buy) and a VGM Score of A.
WLK LYB FTI.WI FMC CC

54
Albemarle: Cyclical Value? Or Super-Cyclical Trap?

2018-07-02 seekingalpha
In 2016, FMC Corp. was in a similar position and I made a 100% return on the stock in 18 months' time.
ALB TWIN FTI.WI FMC CBI

29
Steel Dynamics Plans to Add New Galvanizing Line in Columbus

2018-06-29 zacks
Steel Dynamics, Inc. (STLD - Free Report) recently announced plans to expand its value-added flat roll steel products by adding a new galvanizing line in Columbus, MS. It intends to invest roughly $140 million for adding a third galvanizing line at its Columbus Flat Roll Division. Construction is expected during the next 24 months while operations are likely to start mid-2020. After completion, the company will have nine value-added galvanizing lines with total annual coating capacity of roughly 3.
STLD WLK GM.WS.A GM.WS.B FTI.WI GM.WS.C FMC GM GM.WSB PII CC

6
New Mines Drive Royal Gold, Hurdles at Mount Milligan Ail

2018-06-29 zacks
On Jun 28, we issued an updated research report on Royal Gold, Inc. (RGLD - Free Report) . The company is poised to gain from improved production and progress in ramping up of new mines, as well as its debt-reduction efforts. However, inadequate water supplies at Mount Milligan and volatile gold prices are expected to affect its results. Let’s illustrate these growth factors in detail. Royal Gold to Gain From New Mines Royal Gold expects to start initial production from Peñasquito Pyrite Leach in LaRonde Zone 5 later in calendar year 2018, followed by Cortez Crossroads’ production.
FTI.WI FMC RGLD GM.WS.A KMG GM.WS.B GM.WS.C GM GM.WSB PII MEOH RGL

14
Dempsey Minerals sky high as it pursues lithium strategy in Argentina

2018-06-29 proactiveinvestors.com.au
Dempsey Minerals Ltd (ASX:DMI) is riding the lithium wave with its primary focus on the prolific Lithium Triangle area of Argentina and shares reflect the strategy.
GXY GALXF FTI.WI FMC DMI SQM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to FMC / FMC Corp. on message board site Silicon Investor.

FMC Technologies FMILX u0026amp; FMCSX are the best mutual funds
YFMC HEALTHCARE ( YFM )
CUSIP: 302491303